Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey: A nationwide cross-sectional study

Autor: Şükran Darcan, Rüveyde Bundak, Cengiz Kara, Halil Saglam, Ahmet Uçaktürk, Filiz Tutunculer, Aysegul Yuksel, Tolga Ünüvar, Şükrü Hatun, Huseyin Demirbilek, Abdullah Bereket, Ergun Cetinkaya, Enver Simsek, Damla Gökşen Şimşek, Cigdem Binay, Yaşar Cesur
Přispěvatelé: CESUR, Yaşar, Ondokuz Mayıs Üniversitesi, Uludağ Üniversitesi/Tıp Fakültesi/Çocuk Endokrinolojisi Anabilim Dalı., Sağlam, Halil, C-7392-2019
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Continuous infusion
Single drug dose
Blood Glucose
Male
Pediatrics
Turkey
endocrine system diseases
Cross-sectional study
Endocrinology
Diabetes and Metabolism

medicine.medical_treatment
Glucose blood level
Comorbidity
Prescription
Turkey (republic)
Insulin aspart
0302 clinical medicine
Endocrinology
Glycemic control
immune system diseases
Hemoglobin A
glycosylated

Prevalence
Insulin
Region
030212 general & internal medicine
Child
Children
Endocrinology & metabolism
Disease Management
General Medicine
Type 1 diabetes
Child
Preschool

Insulin detemir
Insulin lispro
Female
Sex ratio
Treatment planning
Celiac Disease
Insulin Dependent Diabetes Mellitus
Patient with Type 1 Diabetes
Human
Risk
Adult
medicine.medical_specialty
Insulin glargine
HbA1c
Adolescent
Insulin dependent diabetes mellitus
030209 endocrinology & metabolism
Major clinical study
Hypoglycemia
Article
A nationwide cross-sectional study-
DIABETES RESEARCH AND CLINICAL PRACTICE
cilt.119
ss.32-40
2016 [Hatun S.
DEMIRBILEK H.
DARCAN Ş.
Yuksel A.
Binay C.
Simsek D. G.
Kara C.
CETINKAYA E.
UNUVAR T.
UCAKTURK A.
et al.
-Evaluation of therapeutics management patterns and glycemic control of pediatric type 1 diabetes mellitus patients in Turkey]

Association
03 medical and health sciences
Disease association
Diabetes mellitus
Dose response
Internal Medicine
medicine
Humans
Clinical evaluation
Intensive care medicine
Isophane insulin
Glycemic
Asthma
Disease duration
Glycated Hemoglobin
business.industry
Pig insulin
Infant
nutritional and metabolic diseases
Glycosylated hemoglobin
medicine.disease
Drug effect
Treatment
Cross-Sectional Studies
Diabetes Mellitus
Type 1

Basal (medicine)
Preschool child
business
Analysis
Popis: Hatun, Sukru/0000-0003-1633-9570; Mengen, Eda/0000-0003-1597-8418; binay, cigdem/0000-0002-7749-8818; UCAKTURK, Seyit Ahmet/0000-0001-8666-4454 WOS: 000381646900004 PubMed: 27423071 Aims: To evaluate the management strategies, glycemic control and complications of pediatric type 1 diabetes mellitus (T1DM) patients in Turkey. Methods: Study included 498 patients with T1DM between the ages 1-18. Data provided from patients' hospital files were recorded on standard case report forms by applicant clinicians within the 3 months of data collection period between October 2012 and July 2013. Results: Mean age of patients was 11.3 +/- 3.8 years. Mean duration of DM was determined as 3.7 +/- 3.1 years. Majority of patients (85.5%) used basal/bolus injection (BBI), and 6.5% used continuous subcutaneous insulin infusion pump. Assessment of glycemic control based on HbA1c levels showed that 29.1% of patients had an HbA1c value 9%(75 mmol/mol). Hypoglycemia was reported in 145 (29.1%) patients and the number of severe hypoglycemic attacks in the last 3 months was 1.0 +/- 2.4. Taking into consideration the carbohydrate count and insulin correction dose and parents with high socioeconomic status was related to have better glycemic control. The most common comorbidities were Hashimoto's thyroiditis/hypothyroidism (6.2%) followed by celiac disease (3.8%), epilepsy(1.2%), and asthma(1.0%). Conclusions: BBI insulin therapy is widely used among pediatric T1DM patients in Turkey. However, despite improvements in treatment facilities and diabetic care, glycemic control is not at a satisfactory level. Therefore, new and comprehensive initiatives require for pediatric T1DM patients with poor glycemic control. Promoting use of carbohydrate count and insulin correction doses may improve the glycemic control of pediatric T1DM in Turkey. (C) 2016 Elsevier Ireland Ltd. All rights reserved. Sanofi Study was funded by Sanofi.
Databáze: OpenAIRE